Jacobio Pharmaceuticals Statements
11
Jacobio Pharmaceuticals Income Statement
B
M
CNY (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
23.185
100
22.384
96.5
0.801
3.5
173.57
748.6
22.9
98.8
189.79
818.6
-188.98
-815.1
-3.644
-15.7
-0.398
-1.7
-192.84
-831.7
—
0
-192.84
-831.7
-0.249
775.91
40.335
100
37.933
94
2.402
6
198.75
492.8
23.715
58.8
221.64
549.5
-219.24
-543.6
52.523
130.2
—
0
-166.28
-412.2
—
0
-166.28
-412.2
-0.216
769.77
41.059
100
37.258
90.7
3.801
9.3
269.06
655.3
19.772
48.2
288.75
703.3
-284.95
-694.01
40.918
99.7
—
0
-244.04
-594.4
—
0
-244.04
-594.4
-0.324
752.31
54.687
100
45.854
83.8
8.833
16.2
176.59
322.9
22.779
41.7
197.59
361.3
-188.76
-345.2
60.931
111.4
—
0
-127.83
-233.7
—
0
-127.83
-233.7
-0.17
751.44
95.12
100
86.846
91.3
8.274
8.7
159.18
167.3
26.05
27.4
177.85
187
-169.58
-178.3
4.991
5.2
—
0
-164.59
-173.03
—
0
-164.59
-173.03
-0.22
748.22
57.689
100
53.133
92.1
4.556
7.9
117.89
204.4
18.22
31.6
136.56
236.7
-132.01
-228.8
-4.589
-8
—
0
-136.6
-236.8
—
0
-136.6
-236.8
-0.183
746.37
486.29
100
44.115
9.1
442.17
90.9
112.72
23.2
41.081
8.4
152.67
31.4
289.5
59.5
-30.64
-6.3
-961.63
-197.7
-702.77
-144.5
—
0
-702.76
-144.5
-0.925
759.65
—
100
—
0
—
0
68.658
0
11.929
0
80.106
0
-80.106
0
2.525
0
-733.32
0
-810.9
0
—
0
-810.9
0
-1.067
759.65